Mechanisms of autoimmune heart disease

Drug Discovery Today: Disease Mechanisms

Volumn 1, Issue 3, 2004, Pages 283-288

  Eriksson, Urs ^a   Penninger, Josef M ^b   Kopf, Manfred ^c  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^c ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHEMOKINE; CYTOKINE; HLA ANTIGEN CLASS 2; INTERLEUKIN 12; INTERLEUKIN 23; TUMOR NECROSIS FACTOR ALPHA;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONGESTIVE CARDIOMYOPATHY; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; DENDRITIC CELL; DISEASE ASSOCIATION; HEART DISEASE; HEART FAILURE; HUMAN; INNATE IMMUNITY; NONHUMAN; REVIEW; TH1 CELL; TH2 CELL; TISSUE INJURY; VIRUS MYOCARDITIS;

EID: 23744460642     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2004.11.011     Document Type: Review

References (40)

1. Feldman, A.M. et al. (2000) Myocarditis. N. Engl. J. Med. 343, 1388-1398
2. Pauschinger, M. et al. (1999) Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation 99, 889-895
3. Pauschinger, M. et al. (1999) Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 99, 1348-1354
4. Calabrese, F. and Thiene, G. (2003) Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects. Cardiovasc. Res. 60, 11-25
5. Caforio, A.L. et al. (2002) Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur. J. Heart Fail. 4, 411-417
6. Schwimmbeck, P.L. et al. (1996) The role of sensitized T-cells in myocarditis and dilated cardiomyopathy. Int. J. Cardiol. 54, 117-125
7. Mason, J.W. et al. (1995) A clinical trial of immunosuppressive and immunomodulatory treatment for myocarditis. N. Engl. J. Med. 333, 269-275
8. Frustaci, A. et al. (2003) Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders vs. non-responders. Circulation 107, 857-863
9. Wojnicz, R. et al. (2001) Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: 2 year follow-up results. Circulation 104, 39-45
10. Fairweather, D. et al. (2001) From infection to autoimmunity. J. Autoimmun. 16, 175-186
11. Klingel, K. et al. (1992) Ongoing enterovirus induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc. Natl. Acad. Sci. USA 89, 314-318
12. Neu, N. et al. (1987) Cardiac myosin induces myocaritis in genetically predisposed mice. J. Immunol. 139, 3630-3636
13. Kodama, M. et al. (1990) A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin. Immunol. Immunopathol. 57, 250-262
14. Li, Y. et al. (2004) Cryptic epitope identified in rat and human cardiac myosin S2 region induces myocarditis in the Lewis rat. J. Immunol. 172, 3225-3234
15. Kurrer, M.O. et al. (2002) Cytokines that regulate autoimmune myocarditis - a mini review. Swiss Med. Wkly. 132, 408-413
16. Afanasyeva, M. et al. (2004) Quantitative analysis of myocardial inflammation by flow cytometry in murine autoimmune myocarditis: correlation with cardiac function. Am. J. Pathol. 164, 807-815
17. Eriksson, U. et al. (2003) Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat. Med. 9, 1484-1490
18. Bachmaier, K. et al. (1999) Chlamydia infections and heart disease linked through antigenic mimicry. Science 283, 1335-1339
19. k on antigen-presenting cells in the heart. J. Exp. Med. 182, 1291-1300
20. Rose, N.R. (2001) Infections, mimics, and autoimmune disease. J. Clin. Invest. 107, 943-944
21. Malkiel, S. et al. (1999) Autoimmune myocarditis does not require B cells for antigen presentation. J. Immunol. 163, 5265-5268
22. Okazaki, T. et al. (2003) Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat. Med. 9, 1477-1483
23. + T-cells regulate major histocompatibility complex II (IA and IE)-dependent susceptibility to coxsackievirus B3-induced autoimmune myocarditis. J. Virol. 73, 5630-5636
24. + Th1 cells. J. Virol. 76, 10785-10790
25. + T cell effectors that cause myocarditis. J. Clin. Invest. 111, 671-680
26. Eriksson, U. et al. (2001) Lethal autoimmune myocarditis in IFN-γ receptor deficient mice: enhanced disease severity by impaired iNOS induction. Circulation 96, 585-591
27. Horwitz, M.S. et al. (2000) Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nat. Med. 6, 693-697
28. Tarrant, T.K. et al. (1999) Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. J. Exp. Med. 189, 219-230
29. Afanasyeva, M. et al. (2001) Experimental autoimmune myocarditis in A/J mice is an Interleukin-4 dependent disease with a Th2 phenotype. Am. J. Pathol. 159, 193-203
30. Eriksson, U. et al. (2001) Dual role of the IL-12/IFN-γ axis in the development of myocarditis: induction by IL-12 and protection by IFN-γ. J. Immunol. 167, 5464-5469
31. Fuse, K. et al. (2003) Polarity of helper T cell subsets represents disease nature and clinical course of experimental autoimmune myocarditis in rats. Clin. Exp. Immunol. 134, 403-408
32. Okura, Y. et al. (1998) Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats. Circ. Res. 82, 1035-1042
33. Fairweather, D. et al. (2003) IL-12 receptor β1 and Toll-like receptor 4 increase IL-1β and IL-18-associated myocarditis and Coxsackievirus replication. J. Immunol. 170, 4731-4737
34. Brombacher, F. et al. (2003) Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol. 24, 207-212
35. Cua, D.J. et al. (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744-748
36. Ratcliffe, N.R. et al. (2000) Identification and characterization of the antigen presenting cell in rat autoimmune myocarditis: evidence of bone marrow derivation and non-requirement for MHC class I compatibility with pathogenic T cells. J. Autoimmun. 15, 369-379
37. Bachmaier, K. et al. (1997) Low-molecular-weight tumor necrosis factor receptor p55 controls induction of autoimmune heart disease. Circulation 95, 655-661
38. Eriksson, U. et al. (2003) Activation of dendritic cells through the IL-1 receptor 1 is essential for the induction of autoimmune myocarditis. J. Exp. Med. 197, 323-341
39. Godsel, L.M. et al. (2001) Prevention of autoimmune myocarditis through the induction of antigen-specific peripheral immune tolerance. Circulation 103, 1709-1714
40. Kaya, Z. et al. (2002) Cutting edge: a critical role for IL-10 in induction of nasal tolerance in experimental autoimmune myocarditis. J. Immunol. 168, 1552-1556